Month: May 2022

LAS VEGAS, May 16, 2022 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTCQB: GLXZ), a developer and distributor of casino table games and enhanced systems for land-based casinos and iGaming content, announced today its financial results for the quarter ended March 31, 2022. Financial Highlights Q1 2022 vs. Q1 2021Revenue increased 38% to $5,919K Adjusted EBITDA increased 58% to $2,673K Net loss of $(14)K vs. net income of $89KBalance Sheet Changes (vs. December 31, 2021)Cash increased 7% to $17,242K Total long-term debt1 (gross) decreased to $60,184K from $60,500K Stockholders’ deficit decreased to $(16,837)K from $(17,286)KExecutive Comments “We got off to a good start for 2022,” said Todd Cravens, President and CEO. “Even though some our high-end customers in London remain affected by worldwide travel disruptions, we had record...

Nears completion of ONWARD™ Phase 3 pivotal trial of AD04 for the treatment of Alcohol Use Disorder; on track to report Phase 3 results in the current quarter Ended first quarter with cash and cash equivalents of $12.7 million CHARLOTTESVILLE, Va., May 16, 2022 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”) a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the first quarter of 2022. William Stilley, Adial’s Chief Executive Officer, stated, “As previously reported, we completed the last patient visit in the ONWARD™ Phase 3 pivotal trial for AD04 for the treatment of alcohol use disorder (AUD) during the first quarter...

BOSTON, May 16, 2022 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics targeting DNA damage response pathways today announced that it has acquired Atrin Pharmaceuticals Inc. (“Atrin”) and reported financial results for the three months ended March 31, 2022. Business Operations Update:  On May 16, 2022 Aprea completed the acquisition of Atrin, a privately held biotechnology company focused on the discovery and development of novel therapeutics targeting proteins in the DNA damage response, or DDR, pathway in oncology through synthetic lethality. The Company believes its cash and cash equivalents as of March 31, 2022 will be sufficient to meet its current projected operating requirements through the second half of 2023. With...

The Company generated positive cashflows from operating activities and eliminated $44 million in derivative liabilities during the first quarter of 2022Empire Quarterly Revenues Quarterly revenues of Empire Services, Inc., a subsidiary of Greenwave Technology Solutions, Inc. (OTC:GWAV)NORFOLK, Va., May 16, 2022 (GLOBE NEWSWIRE) — Greenwave Technology Solutions, Inc. (“Greenwave” or the “Company”) (OTCPink:GWAV) is pleased to report that it generated revenues of $9.92 million during the first quarter of 2022, an increase of 66.91% from the $5.94 million in revenue Empire Services, Inc. (“Empire”) generated in the same period in 2021. Greenwave, through its subsidiary Empire, currently operates 11 metal recycling facilities in Virginia and North Carolina. The Company generated positive cashflows from operating...

PLEASANTON, Calif., May 16, 2022 (GLOBE NEWSWIRE) — Healthcare Triangle, Inc (NASDAQ:HCTI), a leading provider of Healthcare and Life Sciences cloud transformation, managed services and data analytics platform reported results for the quarter ended March 31, 2022. All comparisons below are to the same year-ago period unless otherwise noted. Q1 2022 Financial HighlightsRevenue increased 39% to $11.1 million Gross profit increased 33% to $2.9 million Gross margins at 26%. Achieved first quarterly positive cash flow from operations.Q1 2022 Operational HighlightsAchieved HITRUST Risk-based, 2-year certification to manage risk, improve security posture, and meet compliance requirements. Executed a contract with a major pharma company to build a Neutral Zone to collaborate globally across multiple datasets by employing end-to-end...

BEIJING, May 16, 2022 (GLOBE NEWSWIRE) — Datasea Inc. (NASDAQ: DTSS) (“Datasea” or the “Company”), incorporated in Nevada in September 2014, and a digital technology corporation engaged in three converging and innovative business segments: 5G messaging, acoustic intelligence and smart city in China, today announced financial results for the quarter ended March 31, 2022 and provided an update on its key strategic and operational initiatives. “Datasea delivered record third quarter results with year-over-year growth, mainly driven by accelerating demand for our 5G messaging solutions. This quarter marked a significant inflection point to scale and transform Datasea, underscoring our continued diversification and competitiveness building across 5G messaging, acoustic intelligence, and smart city businesses,” said Zhixin Liu, CEO of...

BOSTON, May 16, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for the first quarter ended March 31, 2022, and recent business progress. TransCode co-founder and Chief Technology Officer, Dr. Zdravka Medarova, indicated, “We believe we remain on track to submit an exploratory Investigational New Drug Application (eIND) this year to test our lead therapeutic candidate, TTX-MC138, in a Phase 0 study in cancer patients with advanced solid tumors. We believe this study has the potential to establish proof-of-mechanism for our platform which ultimately could help us build a broad and diverse pipeline of therapeutics and diagnostics that have the potential to reach previously undruggable genetic targets.” “Additionally,...